expand/collapse risk warning

Trading financial products on margin carries a high risk and is not suitable for all investors. Ensure you fully understand the risks and take appropriate care to manage your risk.

Trading financial products on margin carries a high degree of risk and is not suitable for all investors. Please ensure you fully understand the risks and take appropriate care to manage your risk.

Your capital is at risk.


Bavarian Nordic Stocks

[[ data.name ]]

[[ data.ticker ]]

[[ data.price ]] [[ data.change ]] ([[ data.changePercent ]]%)

Low: [[ data.low ]]

High: [[ data.high ]]







Bavarian Nordic AS (BAVAc.DXE) is a biotechnology company based in Denmark. It specializes in the research, development, and production of vaccines and immunotherapies for infectious diseases and cancer. Founded in 1994, the company has a strong focus on innovative vaccine technology and has established itself as a leading player in the field.

Bavarian Nordic went public in 2005 and is listed on the OMX Nordic Exchange Copenhagen. With a current market cap of 16.59 billion DKK, the company has experienced growth and success in the pharmaceutical industry. It continues to advance its pipeline of vaccine candidates and collaborate with partners globally to address critical public health needs.

Over the past five years, the share price of Bavarian Nordic has experienced fluctuations driven by various factors, including clinical trial results, regulatory approvals, and market sentiment.

During the past five years, the stock has seen its highest price reach a peak of 411.0 DKK in August 2022 and its lowest price dip to a low of 93.1 DKK in December 2018. Throughout its history, the company has achieved notable milestones, such as successfully completing clinical trials for its vaccine candidates and obtaining regulatory approvals for commercialization.

These achievements have had an impact on the company's share price, leading to notable fluctuations. It's worth noting that the stock market is influenced by a multitude of factors, including economic conditions, industry trends, and investor sentiment. Therefore, the share price of Bavarian Nordic and any curiosities associated with it should be considered within the broader context of the company's operations and the overall market conditions at any given time.

Before trading Bavarian Nordic AS stock, it is worth considering the company's competitors in the biopharmaceutical industry. While the specific competitors can vary over time, there are several notable players in the field. Some competitors that are worth considering include:

  • GlaxoSmithKline (GSK): A global pharmaceutical company involved in vaccine development and research.
  • AstraZeneca Plc (AZN): A multinational pharmaceutical company with a broad portfolio of medicines and vaccines.
  • Moderna Inc. (MRNA): A biotechnology company known for its mRNA-based vaccine technology.
  • Pfizer Inc. (PFE): A leading pharmaceutical company engaged in the development and commercialization of vaccines and medicines.

It is important to conduct thorough research and analysis of the competitive landscape, considering factors such as product pipeline, market position, financial performance, and regulatory approvals, to make informed trading decisions regarding Bavarian Nordic AS stock.

Swap long [[ data.swapLong ]] points
Swap short [[ data.swapShort ]] points
Spread min [[ data.stats.minSpread ]]
Spread avg [[ data.stats.avgSpread ]]
Min contract size [[ data.minVolume ]]
Min step size [[ data.stepVolume ]]
Commission and Swap Commission and Swap
Leverage Leverage
Trading Hours Trading Hours

* The spreads provided are a reflection of the time-weighted average. Though Skilling attempts to provide competitive spreads during all trading hours, clients should note that these may vary and are susceptible to underlying market conditions. The above is provided for indicative purposes only. Clients are advised to check important news announcements on our Economic Calendar, which may result in the widening of spreads, amongst other instances.

The above spreads are applicable under normal trading conditions. Skilling has the right to amend the above spreads according to market conditions as per the 'Terms and Conditions'.

Trade [[data.name]] with Skilling

All Hassle-free, with flexible trade sizes and with zero commissions!*

  • Trade 24/5
  • Minimum margin requirements
  • No commission, only spread
  • Fractional shares available
  • Easy to use platform

*Other fees may apply.

Sign up

Why Trade [[data.name]]

Make the most of price fluctuations - no matter what direction the price swings and without capital restrictions that come with buying the underlying asset.


Capitalise on rising prices (go long)


Capitalise on falling prices (go short)


Trade with leverage
Hold larger positions than the cash you have at your disposal


Trade on volatility
No need to own the asset


No commissions
Just low spreads


Manage risk with in-platform tools
Ability to set take profit and stop loss levels